Editorial: Non‐selective beta‐blockers: A lifesaving shield for critically ill patients with acute decompensation of cirrhosis?

Documenti analoghi

• Non‐selective beta‐blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real‐world study
  di: Rahul Kumar, et al.
  Pubblicazione: (2024)
• Impact of non‐selective beta blockers on further decompensation and death in decompensated cirrhosis: Benefit and risk stratification by MELD score
  di: Ting Wang, et al.
  Pubblicazione: (2024)
• Review article: Evaluation and care of the critically ill patient with cirrhosis
  di: Iva Kosuta, et al.
  Pubblicazione: (2024)
• No value of non‐selective beta‐blockers after TIPS‐insertion
  di: Anja Tiede, et al.
  Pubblicazione: (2024)
• Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed
  di: Haibo Jing, et al.
  Pubblicazione: (2024)